Acro Biomedical ACBM Stock
Acro Biomedical Price Chart
Acro Biomedical ACBM Financial and Trading Overview
| Acro Biomedical stock price | 0.0010 USD |
| Previous Close | 2 USD |
| Open | 2 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 2 - 2 USD |
| 52 Week Range | 1.68 - 4.5 USD |
| Volume | 100 USD |
| Avg. Volume | 495 USD |
| Market Cap | 120.08M USD |
| Beta (5Y Monthly) | 0.95672 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.25 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACBM Valuation Measures
| Enterprise Value | 100.96M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 133.94757 |
| Price/Book (mrq) | 249.99998 |
| Enterprise Value/Revenue | 112.621 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Acro Biomedical Stock Price History
| Beta (5Y Monthly) | 0.95672 |
| 52-Week Change | -52.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.5 USD |
| 52 Week Low | 1.68 USD |
| 50-Day Moving Average | 3.14 USD |
| 200-Day Moving Average | 3.71 USD |
ACBM Share Statistics
| Avg. Volume (3 month) | 495 USD |
| Avg. Daily Volume (10-Days) | 170 USD |
| Shares Outstanding | 60.04M |
| Float | 30.04M |
| Short Ratio | N/A |
| % Held by Insiders | 49.96% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1761.12% |
| Gross Margin | 25.26% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -1549.74% |
| Return on Equity (ttm) | -2978.091% |
Income Statement
| Revenue (ttm) | 896.5K USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 259.5K USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -15789575 USD |
| Diluted EPS (ttm) | -0.18 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.19K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 110.58K USD |
| Total Debt/Equity (mrq) | 22.47 USD |
| Current Ratio (mrq) | 4.19 |
| Book Value Per Share (mrq) | 0.008 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -197419 USD |
| Levered Free Cash Flow (ttm) | 5.73M USD |
Profile of Acro Biomedical
| Country | United States |
| State | IN |
| City | Fishers |
| Address | 12175 Visionary Way |
| ZIP | 46038 |
| Phone | 317 286 6788 |
| Website | https://acrobiomedicalco.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. It sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.
Q&A For Acro Biomedical Stock
What is a current ACBM stock price?
Acro Biomedical ACBM stock price today per share is 0.0010 USD.
How to purchase Acro Biomedical stock?
You can buy ACBM shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Acro Biomedical?
The stock symbol or ticker of Acro Biomedical is ACBM.
Which industry does the Acro Biomedical company belong to?
The Acro Biomedical industry is Biotechnology.
How many shares does Acro Biomedical have in circulation?
The max supply of Acro Biomedical shares is 60.04M.
What is Acro Biomedical Price to Earnings Ratio (PE Ratio)?
Acro Biomedical PE Ratio is now.
What was Acro Biomedical earnings per share over the trailing 12 months (TTM)?
Acro Biomedical EPS is -0.25 USD over the trailing 12 months.
Which sector does the Acro Biomedical company belong to?
The Acro Biomedical sector is Healthcare.